Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Thrombosis × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 Prostatic Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Stomach Neoplasms 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Breast Neoplasms, Male 2 Uterine Neoplasms 1 Thrombosis 1 Peritoneal Neoplasms 1 Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Infections 1 Hormone Refractory Prostate Cancer 1 Head and Neck Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinogenesis 1 Breast Neoplasm Female 1 Breast Diseases 1 Amenorrhea 1 Adenocarcinoma 1

Interventions

fluorescein isothiocyanate-keyhole limpet hemocyanin 1 edoxaban 1 apixaban 1 X-Rays 1 Warfarin 1 Technetium Tc 99m Sulfur Colloid 1 Saline Solution 1 Rivaroxaban 1 Physical Therapy Modalities 1 Photons 1 Paclitaxel 1 Musculoskeletal Manipulations 1 Fondaparinux 1 Enoxaparin 1 Docetaxel 1 Dexmedetomidine 1 Dalteparin 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04324346 2021-03-18

PICC&PAC

Swedish Red Cross University College

Phase NA Completed

Infections, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡